Inhibition of Histone Deacetylase 10 Induces Thioredoxin-Interacting Protein and Causes Accumulation of Reactive Oxygen Species in SNU-620 Human Gastric Cancer Cells

Ju‐Hee Lee(Dongguk University), Tae-You Kim(Seoul National University), Sang-Hyun Song(Seoul National University), Yung‐Jue Bang(Seoul National University), Moon-Chang Choi, Sung-Hak Kim(Seoul National University), Eun-Goo Jeong(Seoul National University), Jinah Park(Seoul National University), Jung‐Hyun Park(Ewha Womans University)

Molecules and Cells

July 31, 2010

10.1007/s10059-010-0094-z

Cited by 78

Related Papers

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

|The Lancet|2010|7.3k

Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer

|New England Journal of Medicine|2014|2k

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

|The Lancet|2018|1.3k

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

|The Lancet Oncology|2012|1.3k

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

|The Lancet Oncology|2011|903